BioAtla Inc. (BCAB)
NASDAQ: BCAB
· Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM
-5.46% (1D)
| Bid | 0.39 |
| Market Cap | 28.03M |
| Revenue (ttm) | 11M |
| Net Income (ttm) | -61.88M |
| EPS (ttm) | -1.22 |
| PE Ratio (ttm) | -0.39 |
| Forward PE | -0.43 |
| Analyst | Hold |
| Ask | 0.56 |
| Volume | 595,555 |
| Avg. Volume (20D) | 545,769 |
| Open | 0.54 |
| Previous Close | 0.51 |
| Day's Range | 0.48 - 0.56 |
| 52-Week Range | 0.24 - 2.52 |
| Beta | 0.91 |
About BCAB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCAB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+24.69%
BioAlta shares are trading higher after the compan...
Unlock content with
Pro Subscription
4 months ago
-5.74%
BCAB stock has given up its prior gain. BioAtla shares were trading higher after the company reported better-than-expected Q1 financial results.
